SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VICL (Vical Labs)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1972 55 0 VICL
Emcee:  bob clark Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1572Atkins + Associates Hosts First Annual San Diego BioBusiness Investor Tour SAbob zagorin-3/26/2003
1571Vical Announces Webcast of CEO Presentation at SG Cowen Healthcare Conference bob zagorin-3/14/2003
1570Genetic Engineering News Reports Biofirms Devising Anti-Biowarfare Agents 11 Mabob zagorin-3/11/2003
1569San Diego Biotechnology Firm to Test Safety of Its Anthrax Vaccine on Humans bob zagorin-3/11/2003
1568Vical stock soars as company tests anthrax vaccine NEW YORK, March 10 (Reuters)bob zagorin-3/10/2003
1567>>SAN DIEGO, March 10 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaqtuck-3/10/2003
1566Vical Plans Clinical Testing of Anthrax Vaccine by Year-End 2003 SAN DIEGO, Mbob zagorin-3/10/2003
1565Vical Announces Webcast of CEO Presentation at BIO CEO & Investor Conferencebob zagorin-2/20/2003
1564Vical Announces Fourth-Quarter and Year-End 2002 Financial Results SAN DIEGO,bob zagorin-2/11/2003
1563Vical Targets Development of Novel Cytomegalovirus Vaccine SAN DIEGO, Feb 6, bob zagorin-2/6/2003
1562Vical Announces News Release and Conference Call Schedule For Fourth Quarter Andbob zagorin-2/3/2003
1561Know What, I'm curious. It says in the financials that VICL does not anticEVENT HORIZON III-1/25/2003
1560Here's an unequivocal response to my ill-posed question on the Valuation thrA.J. Mullen-1/17/2003
1559Biomaven suggested an answer to my question on the Valuation thread. He pointedA.J. Mullen-1/15/2003
1558I heard that report on the radio, but why should the "Naked DNA" approA.J. Mullen-1/15/2003
1557i think i'm the only one here but the following story indicates to me why vibob zagorin-1/15/2003
1556Epimmune Gets FDA Clearance To Start Vaccine Trials DOW JONES NEWSWIRES SAN DIbob zagorin-1/13/2003
1555January 9, 2003 Military Says It Can't Make Enough Vaccines for Troops By ERbob zagorin-1/9/2003
1554Schering, Valentis In Multi-Product Gene Therapy Alliance NEW YORK (Reuters Hebob zagorin-12/23/2002
1553November 21, 2002 Vaccine Appears to Prevent Cervical Cancer By DENISE GRADY (NYbob zagorin-11/21/2002
1552Vical Announces Third-Quarter 2002 Financial Results SAN DIEGO, Nov. 4 /PRNewswbob zagorin-11/5/2002
1551Vical Announces News Release and Conference Call Schedule for Third Quarter 2002bob zagorin-10/29/2002
1550Nobel Laureate To Chair CytRx Scientific Advisory Board Meeting LOS ANGELES, bob zagorin-10/14/2002
1549Vical Announces Webcast of CEO Presentation At UBS Warburg Global Life Sciences bob zagorin-10/4/2002
1548Original Source: The Institute For Genomic Research Date Posted: 10/3bob zagorin-10/3/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News